Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patients.

Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patients.

Item
http://www.wikidata.org/entity/Q44343787
The effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responsesAntinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics.Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study.Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agentsLong-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis.Infliximab in the treatment of rheumatoid arthritisClinical application and evaluation of anti-TNF-alpha agents for the treatment of rheumatoid arthritis.The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside.Antinuclear antibody (ANA) testing in patients treated with biological DMARDs: is it useful?Etanercept for treating axial spondyloarthritis.Etanercept for the treatment of non-radiographic axial spondyloarthritis.Anti-nuclear antibody positivity and the use of certolizumab in inflammatory bowel disease patients who have had arthralgias or lupus-like reactions from infliximab or adalimumab.Association of anti-Ro/SSA antibody with response to biologics in patients with rheumatoid arthritis.
P2860

Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patients.

Item
http://www.wikidata.org/entity/Q44343787
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Impact of three anti-TNFalpha ...... d spondylarthropathy patients.
@en
Impact of three anti-TNFalpha ...... d spondylarthropathy patients.
@nl
type
label
Impact of three anti-TNFalpha ...... d spondylarthropathy patients.
@en
Impact of three anti-TNFalpha ...... d spondylarthropathy patients.
@nl
prefLabel
Impact of three anti-TNFalpha ...... d spondylarthropathy patients.
@en
Impact of three anti-TNFalpha ...... d spondylarthropathy patients.
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Impact of three anti-TNFalpha ...... nd spondylarthropathy patients
@en
P2093
P2888
P304
P31
P356
P433
P478
P50
P577
P698